161 related articles for article (PubMed ID: 23385626)
1. One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity.
Villa M; Muñoz P; Ahumada-Castro U; Paris I; Jiménez A; Martínez I; Sevilla F; Segura-Aguilar J
Neurotox Res; 2013 Jul; 24(1):94-101. PubMed ID: 23385626
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.
Fuentes P; Paris I; Nassif M; Caviedes P; Segura-Aguilar J
Chem Res Toxicol; 2007 May; 20(5):776-83. PubMed ID: 17425337
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity.
Lozano J; Muñoz P; Nore BF; Ledoux S; Segura-Aguilar J
Chem Res Toxicol; 2010 Sep; 23(9):1492-6. PubMed ID: 20849151
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity.
Muñoz P; Paris I; Sanders LH; Greenamyre JT; Segura-Aguilar J
Biochim Biophys Acta; 2012 Jul; 1822(7):1125-36. PubMed ID: 22483869
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.
Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J
Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711
[TBL] [Abstract][Full Text] [Related]
6. DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity.
Muñoz P; Cardenas S; Huenchuguala S; Briceño A; Couve E; Paris I; Segura-Aguilar J
Toxicol Sci; 2015 May; 145(1):37-47. PubMed ID: 25634539
[TBL] [Abstract][Full Text] [Related]
7. MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.
Aguilar Hernández R; Sánchez De Las Matas MJ; Arriagada C; Barcia C; Caviedes P; Herrero MT; Segura-Aguilar J
Neurotox Res; 2003; 5(6):407-10. PubMed ID: 14715443
[TBL] [Abstract][Full Text] [Related]
8. Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line.
Paris I; Dagnino-Subiabre A; Marcelain K; Bennett LB; Caviedes P; Caviedes R; Azar CO; Segura-Aguilar J
J Neurochem; 2001 Apr; 77(2):519-29. PubMed ID: 11299314
[TBL] [Abstract][Full Text] [Related]
9. DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers.
Muñoz PS; Segura-Aguilar J
Neurotox Res; 2017 Oct; 32(3):362-367. PubMed ID: 28478529
[TBL] [Abstract][Full Text] [Related]
10. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor.
Díaz-Véliz G; Mora S; Gómez P; Dossi MT; Montiel J; Arriagada C; Aboitiz F; Segura-Aguilar J
Pharmacol Biochem Behav; 2004 Feb; 77(2):245-51. PubMed ID: 14751451
[TBL] [Abstract][Full Text] [Related]
12. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.
Leak RK; Liou AK; Zigmond MJ
J Neurochem; 2006 Nov; 99(4):1151-63. PubMed ID: 16956375
[TBL] [Abstract][Full Text] [Related]
13. Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line.
Paris I; Muñoz P; Huenchuguala S; Couve E; Sanders LH; Greenamyre JT; Caviedes P; Segura-Aguilar J
Toxicol Sci; 2011 Jun; 121(2):376-88. PubMed ID: 21427056
[TBL] [Abstract][Full Text] [Related]
14. Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine.
Hayes J; Tipton KF; Bianchi L; Corte LD
Brain Res Bull; 2001 May; 55(2):239-45. PubMed ID: 11470322
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.
Burgaz S; García C; Gómez-Cañas M; Navarrete C; García-Martín A; Rolland A; Del Río C; Casarejos MJ; Muñoz E; Gonzalo-Consuegra C; Muñoz E; Fernández-Ruiz J
Mol Cell Neurosci; 2021 Jan; 110():103583. PubMed ID: 33338634
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures.
Siebert A; Desai V; Chandrasekaran K; Fiskum G; Jafri MS
J Neurosci Res; 2009 May; 87(7):1659-69. PubMed ID: 19125416
[TBL] [Abstract][Full Text] [Related]
18. Possible role of salsolinol quinone methide in the decrease of RCSN-3 cell survival.
Martinez-Alvarado P; Dagnino-Subiabre A; Paris I; Metodiewa D; Welch CJ; Olea-Azar C; Caviedes P; Caviedes R; Segura-Aguilar J
Biochem Biophys Res Commun; 2001 May; 283(5):1069-76. PubMed ID: 11355881
[TBL] [Abstract][Full Text] [Related]
19. On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo.
Herrera-Soto A; Díaz-Veliz G; Mora S; Muñoz P; Henny P; Steinbusch HWM; Segura-Aguilar J
Neurotox Res; 2017 Jul; 32(1):134-140. PubMed ID: 28285345
[TBL] [Abstract][Full Text] [Related]
20. Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.
Saura J; Parés M; Bové J; Pezzi S; Alberch J; Marin C; Tolosa E; Martí MJ
J Neurochem; 2003 May; 85(3):651-61. PubMed ID: 12694391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
